Description
Research Overview
Selank is a synthetic heptapeptide composed of Thr-Lys-Pro-Arg-Pro-Gly-Pro that has been investigated in experimental research involving neuropeptide signalling, GABAergic mechanisms and central nervous system activity.
Research Focus
Research has examined Selank in relation to GABA-related signalling, neurochemical regulation, anxiety-related behavioural models and interactions involving endogenous regulatory peptides. Experimental studies have also investigated changes in gene expression and cellular signalling following Selank exposure.
Scientific Context
Preclinical research has explored possible mechanisms through which Selank may influence GABAergic and neuropeptide systems. Limited human research has also investigated Selank in specific clinical populations, including older clinical studies examining anxiety-related conditions. The available evidence remains limited and should be interpreted within the context of the specific experimental model and study design.
Important Research Note
Selank remains an investigational research compound. Available evidence includes preclinical research and limited clinical literature, with substantial uncertainty regarding broader clinical applications, long-term safety and therapeutic efficacy. Research findings should not be interpreted as evidence that Selank is safe or effective for anxiety, cognitive enhancement, mood regulation or any other human application.
For research purposes only. Not intended for human or veterinary use.
